Related Experiment Video
Updated: Jul 16, 2026

Ex Utero Electroporation and Organotypic Slice Culture of Mouse Hippocampal Tissue
Published on: March 4, 2015
Human TIEG2/KLF11 induces oligodendroglial cell death by downregulation of Bcl-XL expression
Z Wang1, B Spittau, M Behrendt
1Center of Anatomy, Department of Neuroanatomy, University of Goettingen, Goettingen, Germany.
Abstract:
TGF-beta-induced apoptosis is essential for embryonic development and mainteanance of adult tissues. Impairment of the apoptotic pathway, regulated by TGF-beta, plays a center role in tumorigenesis and manifestations of different diseases. TIEG2/KLF11 is a recently identified human TGF-beta-inducible zinc finger protein belonging to the family of Sp1/KLF-like transcription factors. In human and murine tissues it has been shown that TIEG1 and TIEG2 induce apoptosis and inhibit cell growth. Since TGF-beta and Tieg1 are able to induce apoptosis in the oligodendroglial cell line OLI-neu, we analysed the ability of TIEG2 to mimic the effects observed after treatment with TGF-beta and overexpression of Tieg1. Herein we report that TIEG2 induces Caspase3-dependent apoptosis in murine OLI-neu cells. Furthermore, we could demonstrate that TIEG2 decreases the levels of the anti-apoptotic protein Bcl-X(L) and inhibits transcription driven by the Bcl-X(L) promoter. These data suggest that TIEG2 serves as a downstream mediator of TGF-beta, bridging TGF-beta-dependent signaling to the intracellular pathway of apoptosis.
Insights
Transforming growth factor-beta (TGF-beta) signaling regulates apoptosis, crucial for development and disease. TIEG2 protein mediates TGF-beta
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Biology
Background:
- Transforming growth factor-beta (TGF-beta) signaling is vital for apoptosis, impacting development and disease.
- Dysregulation of apoptosis is implicated in tumorigenesis and various pathologies.
- TIEG2/KLF11, a TGF-beta-inducible transcription factor, is a novel player in this pathway.
Purpose of the Study:
- To investigate the role of TIEG2 in inducing apoptosis in oligodendroglial cells.
- To determine if TIEG2 mimics the apoptotic effects of TGF-beta and TIEG1.
- To elucidate the downstream mechanisms by which TIEG2 mediates apoptosis.
Main Methods:
- Treatment of murine OLI-neu cells with TIEG2.
- Caspase-3 activity assays to measure apoptosis.
- Western blotting to assess protein levels (e.g., Bcl-X(L)).
- Reporter assays to evaluate promoter activity (e.g., Bcl-X(L) promoter).
Main Results:
- TIEG2 induces Caspase-3-dependent apoptosis in OLI-neu cells.
- TIEG2 downregulates the anti-apoptotic protein Bcl-X(L).
- TIEG2 inhibits transcriptional activity driven by the Bcl-X(L) promoter.
Conclusions:
- TIEG2 acts as a downstream mediator of TGF-beta signaling.
- TIEG2 bridges TGF-beta signaling to the intracellular apoptotic machinery.
- TIEG2's role in apoptosis suggests its involvement in TGF-beta-related cellular processes and diseases.
More Related Videos
08:55Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
10:45Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization
Published on: January 13, 2012
Related Concept Videos
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway